________________________________________________________________________________________________________________________________

xxxTeeth to the Convention on Biological Diversity

Where is the Convention on Biological Diversity (CBD) heading after the Nagoya Protocol? What protection has to be there, if it has to show its teeth? The World Intellectual Property Organization (WIPO) plays a vital role in the enforcement of CBD.

Where is the Convention on Biological Diversity (CBD) heading after the Nagoya Protocol? What protection has to be there, if it has to show its teeth? The World Intellectual Property Organization (WIPO) plays a vital role in the enforcement of CBD Countries in Asia, Africa and Latin America are casting their own understanding of the Convention on Biological Diversity (CBD) into individual laws thereby creating heterogeneous even conflicting regulations as well as undermining the intention of CBD. The World Intellectual Property Organization (WIPO) is working towards bringing stakeholders together and support global enforcement of the Nagoya Protocol.

CBD brings together experts to draft a “Strategic Framework for Capacity-building and Development in Support of the Effective Implementation of the Nagoya Protocol on Access and Benefit-sharing” at Montréal. Why does it take years to mature into an agreement on what everybody is d’accord in principle?

In May 2011 Dr Christian Wichard, Deputy Director General of WIPO provided background and insights on substantive and procedural issues around legal protection of genetic resources as well as access and fair sharing of benefits from their commercial exploitation. A vivid account of CBD workings and unresolved issues exclusive to readers of B2Bioworld.

If you like to read this article, you can purchase it now

Please notice, when purchasing articles you agree to B2Bioworld's Terms and Conditions

Read Now - Please select your license (Prices incl. 7% VAT)

Article free of advertisement - 7 pages

Full Company License enquire here

Back to section

Related Editorial Articles

Easier Access to Patent Claims Encoded in Chinese
EPO catalyzes innovation of intercontinental IP systems. Questions about Russia’s intentions

Is that worth a dollar, or a million dollars?
Ed Torres, Managing Director of Lilly Ventures on the Fund’s input to Eli Lilly’s business development

Improving the IP System on a global scale: A view from Japan
Sadao Nagaoka, Institute of Innovation Research, and Chief Policy Adviser to the Japanese Government

TALEs, Zinc Fingers, or Meganucleases
A Practice View from Crop Research and Breeding by Johan Botterman, Head of Product Research Bayer CropScience

Patenting Stem Cells – Behind the Front Stages
The patentability of stem cells is of continuing debate. The article outlines the legal approach to stem cells as it informs solving juridical problems

The Myriad Way
Peter D Meldrum, CEO of the genetics company about battles on patents, cancer chips, and competitors in commercial academia

The Global Dimension of EU Health and Food Policies
Paola Testori-Coggi, Director-General for Health and Consumers, European Commission

FAO: Major shifts expected in operations
José Graziano da Silva, new Director-General, answers probing questions